Home
Home

Stiefel Labs

GSK unit pays £146 million to get Basilea eczema drug

GSK unit pays £146 million to get Basilea eczema drug
Pharma Times, UK

Stiefel receives US FDA approval of Fabior™ Foam, 0.1%

Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
Yahoo/PR NewsWire

Did Stiefel undervalue employee shares before GSK buyout?

Did Stiefel undervalue employee shares before GSK buyout?
Fierce Pharma

S.E.C. Accuses Stiefel Labs and Its Ex-Chief of Fraud

S.E.C. Accuses Stiefel Labs and Its Ex-Chief of Fraud
NY Times, NY

Stiefel case class action blocked

Stiefel case class action blocked
Bizjournals.com

News

GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
PR-USA
»

News

Glaxo’s Stiefel Buy: No Blockbusters, Please
WSJ Online
»

News

GlaxoSmithKline to Buy Stiefel Laboratories
TheStreet.com
»

News

J&J, Novartis Seen As Suitors for Stiefel Labs
TheStreet.com
»